Christian Bailly, Author at Oncowitan

Scorbo-betaïne® (betaine ascorbate), from Laboratoires Fournier (Dijon, F), 1972

(more…)

By Christian Bailly, 1 week22 January 2023 ago

New publication: Identification of an inhibitor of the PD-1/PD-L1 checkpoint in oncology.

(more…)

By Christian Bailly, 1 week22 January 2023 ago

New publication: A series of anticancer natural products identified as α-tubulin binders.

(more…)

By Christian Bailly, 1 week22 January 2023 ago

Striadyne® (adenosine triphosphate, ATP), from Laboratoires du Dr J. Auclair (Montrouge, F), 1971

(more…)

By Christian Bailly, 3 weeks8 January 2023 ago

CDMO activity: Head of Development & Manufacturing for Polygon Therapeutics (Sept 2022)

Development & Manufacturing of POLYGON therapeutic leader product PLG-101, a monoclonal antibody for the treatment of cardiovascular diseases (myocardial infacrtion). The antibody PLG-101 aims to enhance post-ischemic cardiac remodeling. Christian Bailly (Oncowitan) brings his exertise to guide the manufacturing of the producing cell line and GMP-made antibody, for subsequent clinical Read more…

By Christian Bailly, 1 month31 December 2022 ago